Soft tissue lesions: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
=Introduction= | =Introduction= | ||
==WHO classification of soft tissue lesions/tumours== | ==WHO classification of soft tissue lesions/tumours== | ||
===Morphologic grouping<ref name=Ref_WMSP601-3>{{Ref WMSP|601-3}}</ref> | ===Morphologic grouping=== | ||
These include:<ref name=Ref_WMSP601-3>{{Ref WMSP|601-3}}</ref> | |||
#[[Adipocytic tumours]]. | #[[Adipocytic tumours]]. | ||
#[[Fibroblastic/myofibroblastic tumours]]. | #[[Fibroblastic/myofibroblastic tumours]]. | ||
| Line 14: | Line 15: | ||
#[[Soft tissue lesions#Tumours of uncertain differentiation|Tumours of uncertain differentiation]]. | #[[Soft tissue lesions#Tumours of uncertain differentiation|Tumours of uncertain differentiation]]. | ||
===Biologic potential grouping<ref>{{Ref WMSP|598-604}}</ref> | ===Biologic potential grouping=== | ||
These include:<ref>{{Ref WMSP|598-604}}</ref> | |||
#Benign. | #Benign. | ||
#Intermediate (locally aggressive). | #Intermediate (locally aggressive). | ||